US Equities Analysis

RTX — RTX Corporation

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 13.18%
Profit Margins 8.03%
Return on Equity 11.57%
Return on Assets 4.05%
Free Float 1.25B
Dividend Yield 1.48%
Short Int % Utilisation 1.23%

2.2 Growth

Metric Value
Revenue Growth 8.7%
Free Cash Flow 7.23B
EBITDA 17.87 (Ratio)
Enterprise Value 272.79B
EV/Revenue 3.02
EV/EBITDA 17.87

Revenue growth of 8.7% indicates steady, moderate expansion.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 52.24%
Risk / Std Dev (Ann.)* 25.86%
1-Year Price Return* 46.85%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $222.97
52-Week Range $150.61 – $226.88
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $88.60B
Prior annual revenue $80.74B
EBIT $10.57B
Tax rate 19.05%
NOPAT = EBIT × (1 − tax rate) $8.55B
Forecast start-growth basis 9.74%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $8.55B
Add: depreciation & amortisation $4.38B
Less: capital expenditure -$3.12B
Less/(add): working-capital cash-flow movement -$1.27B
Current unlevered FCFF $8.54B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 9.74% $9.39B $4.80B -$3.42B -$1.40B $9.37B $9.10B
2 7.93% $10.13B $5.19B -$4.07B -$1.51B $9.74B $8.92B
3 6.12% $10.75B $5.50B -$4.71B -$1.60B $9.94B $8.59B
4 4.31% $11.22B $5.74B -$5.33B -$1.67B $9.96B $8.12B
5 2.50% $11.50B $5.88B -$5.88B -$1.71B $9.78B $7.52B

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 0.29
Cost of equity 6.33%
Pre-tax cost of debt 4.45%
WACC 6.01%
WACC validation requires assumption review

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $285.39B
Implied terminal EV / EBITDA 14.21x
Terminal value as % of enterprise value 83.45%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $42.26B
Present value of terminal value $213.12B
Indicated enterprise value $255.38B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $255.38B
Less: gross interest-bearing debt $39.51B
Add: cash and equivalents $7.43B
Add: affiliate investments $0.00
Less: minority interests $1.89B
Indicated common equity value $221.42B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 1,356,400,000.00
Share-count basis reported diluted weighted-average shares
Current market price $224.13
DCF indicative value per share $163.24
Indicative value vs. market price -27.17%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range review required
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% within review band

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 3/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:48:04.320331 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

us-equity stock equity rtx industrials aerospace--defense nasdaq